Guardant Health
GH
#1873
Rank
โ‚น1.039 T
Marketcap
โ‚น7,925
Share price
0.42%
Change (1 day)
106.37%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -โ‚น36.59 Billion

According to Guardant Health 's latest financial reports the company's current earnings are โ‚น0.98 Billion. , an increase over its 2024 earnings that were of -โ‚น40.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น38.83 Billion-4.03%
2024 -โ‚น40.46 Billion-9.12%
2023 -โ‚น44.53 Billion-26.73%
2022 -โ‚น60.77 Billion69.96%
2021 -โ‚น35.76 Billion56.35%
2020 -โ‚น22.87 Billion252.69%
2019 -โ‚น6.49 Billion-17.22%
2018 -โ‚น7.84 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-โ‚น57.43 Billion 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น24.94 Billion-35.79%๐Ÿ‡บ๐Ÿ‡ธ USA